Mirae Asset Global Investments
CLPT icon

Mirae Asset Global Investments’s ClearPoint Neuro CLPT Stock Holding History

Mirae Asset Global Investments’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13,378
Closed -$90.8K – 2467
2023
Q4 		$90.8K Hold
13,378
– – ﹤0.01% 2480
2023
Q3 		$67K Hold
13,378
– – ﹤0.01% 2523
2023
Q2 		$96.9K Buy
+13,378
New +$114K ﹤0.01% 2520

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mirae Asset Global Investments's CLPT Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of ClearPoint Neuro (CLPT) in Q1 2024, closing a stake of 13,378 shares — an estimated $90.8K sold.

Mirae Asset Global Investments first reported a position in CLPT in Q2 2023 and held it in 3 quarters. The position peaked at $96.9K in Q2 2023. 81 funds tracked by Wall St. Rank hold CLPT as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining ClearPoint Neuro position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 13,378 ClearPoint Neuro shares in Q1 2024, an estimated $90.8K.
  • Mirae Asset Global Investments first reported a position in ClearPoint Neuro in Q2 2023 and held it in 3 quarters.
  • Mirae Asset Global Investments's ClearPoint Neuro position peaked at $96.9K in Q2 2023.
  • 81 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.